Company Filing History:
Years Active: 2011
Title: Chih-Hsiang Huang: Innovator in Neurodegenerative Disease Research
Introduction
Chih-Hsiang Huang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target histone deacetylase (HDAC). His work is crucial in the fight against neurodegenerative diseases and other related conditions.
Latest Patents
Chih-Hsiang Huang holds a patent for "Compounds for the inhibition of histone deacetylase." This invention relates to a compound represented by a specific formula and includes pharmaceutically acceptable salts, stereoisomers, enantiomers, prodrugs, and solvates thereof. The compounds are designed to enhance neurite outgrowth and are useful in preventing or treating diseases associated with HDAC, particularly tumor or cell proliferative diseases. Notably, these compounds can be employed as agents for anti-neurodegenerative diseases and human spinal muscular atrophy (SMA). He has 1 patent to his name.
Career Highlights
Chih-Hsiang Huang is associated with Naturewise Biotech and Medicals Corporation, where he applies his expertise in biotechnology to develop innovative solutions for health challenges. His research focuses on creating effective treatments for debilitating diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Chih-Hsiang Huang has worked alongside talented colleagues, including Chung-Yang Huang and Chia-Nan Chen. Their collaborative efforts contribute to the advancement of research in the field of biotechnology.
Conclusion
Chih-Hsiang Huang is a dedicated inventor whose work in developing HDAC inhibitors holds promise for treating neurodegenerative diseases. His contributions to biotechnology reflect a commitment to innovation and improving health outcomes for patients worldwide.